Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)WithdrawnNCT05514912What this trial is testingPreoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC TrialWho this might be right forResectable Intrahepatic CholangiocarcinomaStage 0 Intrahepatic Cholangiocarcinoma AJCC v8Stage I Intrahepatic Cholangiocarcinoma AJCC v8+2 more Emory University
Testing effectiveness (Phase 2)Study completedNCT00004910What this trial is testingEndoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more Northwestern University
Early research (Phase 1)Study completedNCT01825603What this trial is testingADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerWho this might be right forAmpulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+17 more University of Nebraska 17
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT00266097What this trial is testingOxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer UNC Lineberger Comprehensive Cancer Center 23
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Early research (Phase 1)Study completedNCT00544193What this trial is testingGemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more City of Hope Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT03602079What this trial is testingStudy of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneWho this might be right forHER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more Klus Pharma Inc. 49
Early research (Phase 1)Study completedNCT00003411What this trial is testingRadiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer University of Pittsburgh
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Early research (Phase 1)Study completedNCT00003046What this trial is testingInterleukin-12 in Treating Patients With Cancer in the AbdomenWho this might be right forAnal CancerColorectal CancerGallbladder Cancer+2 more M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07186842What this trial is testingA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Who this might be right forAdvanced Solid Cancers BioNTech SE 245
Very early researchNot Yet RecruitingNCT06196658What this trial is testingEarly Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct CancerWho this might be right forPancreatic CancerAdvanced Biliary Cancer Zhang Xiaofeng,MD 6
Testing effectiveness (Phase 2)Study completedNCT00003923What this trial is testingPhotodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more Memorial Sloan Kettering Cancer Center 4
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30